检索结果 - Yong‐Oon Ahn
- Showing 1 - 11 results of 11
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
Phase I Study of Random Healthy Donor–Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors 由 Yaewon Yang, Okjae Lim, Tae Min Kim, Yong‐Oon Ahn, Hana Choi, Hyejin Chung, Bokyung Min, Jung Hyun Her, Sung Yoo Cho, Bhumsuk Keam, Se‐Hoon Lee, Dong‐Wan Kim, Yu Kyeong Hwang, Dae Seog Heo
出版 2016Artigo -
11
Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma 由 Chan-Young Ock, Sehui Kim, Bhumsuk Keam, Soyeon Kim, Yong‐Oon Ahn, Eun‐Jae Chung, Jin-Ho Kim, Tae Min Kim, Seong Keun Kwon, Yoon Kyung Jeon, Kyeong Chun Jung, Dong‐Wan Kim, Hong-Gyun Wu, Myung‐Whun Sung, Dae Seog Heo
出版 2017Artigo
相关主题
Biology
Immunology
Cell biology
Medicine
Cancer research
Immune system
Internal medicine
Biochemistry
Cancer
Stem cell
Cytokine
Gene
Genetics
Haematopoiesis
T cell
Biotechnology
CD8
Cytotoxic T cell
Head and neck cancer
Head and neck squamous-cell carcinoma
Immunotherapy
In vitro
In vivo
Innate lymphoid cell
Janus kinase 3
Lung cancer
Lymphoma
Lymphopoiesis
MAPK/ERK pathway
Natural killer T cell